Alzamend Neuro

Developer of immunotherapies for neurodegenerative disease

placeSalt Lake City, Utah, United States calendar_todayFounded 2016 groups4 employees language alzamend.com

Registered entities

Social engagement

Social engagement: 1.9K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

17 Jun 2026
Product launch
AL001
Coming soon